Harmony Biosciences

About:

Harmony Biosciences is a pharmaceutical company that develops and commercializes novel therapies for rare neurological disorders.

Website: https://www.harmonybiosciences.com

Twitter/X: HarmonyBio

Top Investors: Fidelity, Novo Holdings, Valor Equity Partners, OrbiMed, venBio Partners

Description:

Harmony Biosciences is a pharmaceutical company headquartered in Plymouth Meeting, PA. The company was established in October 2017 with a vision to develop and commercialize innovative therapies for people living with rare neurological disorders who have unmet medical needs.

Total Funding Amount:

$1.68B

Estimated Revenue Range:

$500M to $1B

Headquarters Location:

Plymouth Meeting, Pennsylvania, United States

Founded Date:

2017-10-01

Contact Email:

info(AT)harmonybiosciences.com

Founders:

Jeff Aronin

Number of Employees:

251-500

Last Funding Date:

2024-10-30

IPO Status:

Public

Industries:

Biopharma

Biotechnology

Health Care